CP
GBT

CenterBook Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History

CenterBook Partners’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,046
Closed -$412K – 482
2022
Q3 		$412K Buy
+6,046
New +$333K 0.08% 302

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CenterBook Partners's GBT Position: Q4 2022 in Review

CenterBook Partners sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 6,046 shares — an estimated $412K sold.

CenterBook Partners first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $412K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • CenterBook Partners reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • CenterBook Partners sold 6,046 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $412K.
  • CenterBook Partners first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • CenterBook Partners's Global Blood Therapeutics, Inc. position peaked at $412K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on CenterBook Partners's 13F filing for Q4 2022, filed 13 Feb 2023.